NORTH AMERICA IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

NORTH AMERICA IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

  • September 2018 •
  • 101 pages •
  • Report ID: 5228603 •
  • Format: PDF
KEY FINDINGS
The North America in-vitro fertilization market is forecasted to evolve with a CAGR of 10.11% from 2018 to 2026. Several end-user segments that deploy the IVF techniques include, cryobanks, hospitals and research laboratories, fertility and surgical centers.

MARKET INSIGHTS
Canada and the United States are the primary markets in this region.The United States captured a major share of the North American market in the year 2017.

The high occurrence of infertility in old age and significant use of contraceptive drugs in the U.S. are some of the factors which are influencing the market demand. The IVF market is mainly segmented on the basis of end-users, procedures, and product. The Canadian in-vitro fertilization market is also growing significantly due to factors like older age in women, the presence of sexually transmitted disease that causes blockage in the fallopian tubes, hormonal imbalance, etc.

COMPETITIVE INSIGHTS
The Baker Company Inc, Halotech DNA, Auxogyn, Esco Micro Pte. Ltd, Ovascience, Thermo Fisher Scientific Inc, Irvine Scientific (Subsidiary of Nippon Mining Holdings), Cook Medical Inc, Ferring Pharmaceuticals, Andrology Solutions, Vitrolife Ab, Genea, Copper Surgical Inc, Ivftech Aps and Merck Serono are some of the competing players in the In-vitro fertilization market.